Pfizer and Moderna stocks bucked the trend and soared after the news of a potential "deadlier version of Covid." ...

Pfizer (NYSE: PFE) has been around for 175 years, but the company's revenue soared to its highest ever only in more recent ...

The virus does not enter human cells as readily as SARS-CoV-2 does, the Chinese researchers reported in the journal Cell, ...

An archived Facebook post claimed that Pfizer has released a list of side effects for COVID vaccine. The claim by the user is ...

Researchers have discovered a virus that could enter human cells in a similar way to COVID-19. But they caution it's much ...

Researchers at the Wuhan Institute of Virology in China said they discovered a new coronavirus in bats that enters cells ...

Pfizer may appeal to income investors, but growth prospects remain uncertain. Read why PFE stock might struggle to gain ...

Moderna Inc. rose by as much as 6.6%, while Novavax Inc. climbed 7.8%. American depositary receipts of BioNTech SE, the partner of Pfizer in the development of the Covid vaccine, surged by 5.1%, and ...

Paxlovid may not decrease the risk for hospitalization or death in older adults vaccinated against COVID-19 as much as ...

Paxlovid does not significantly reduce COVID-19 hospitalization and mortality among vaccinated older adults, according to new UCLA-led research.

An epidemiologist said the Franklin County resolution was "based on conspiracy and misinformation against the COVID-19 ...